DMAC
Price
$5.42
Change
-$0.19 (-3.39%)
Updated
Jun 9 closing price
Capitalization
292.32M
63 days until earnings call
Intraday BUY SELL Signals
FHTX
Price
$3.87
Change
+$0.16 (+4.31%)
Updated
Jun 9 closing price
Capitalization
227.22M
62 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

DMAC vs FHTX

Header iconDMAC vs FHTX Comparison
Open Charts DMAC vs FHTXBanner chart's image
DMAC vs FHTX Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
DMAC vs. FHTX commentary
Jun 10, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DMAC is a StrongBuy and FHTX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 10, 2026
Stock price -- (DMAC: $5.43 vs. FHTX: $3.87)
Brand notoriety: DMAC and FHTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DMAC: 204% vs. FHTX: 95%
Market capitalization -- DMAC: $292.32M vs. FHTX: $227.22M
DMAC [@Biotechnology] is valued at $292.32M. FHTX’s [@Biotechnology] market capitalization is $227.22M. The market cap for tickers in the [@Biotechnology] industry ranges from $113.14B to $0. The average market capitalization across the [@Biotechnology] industry is $1.87B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DMAC’s FA Score shows that 0 FA rating(s) are green whileFHTX’s FA Score has 0 green FA rating(s).

  • DMAC’s FA Score: 0 green, 5 red.
  • FHTX’s FA Score: 0 green, 5 red.
According to our system of comparison, DMAC is a better buy in the long-term than FHTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DMAC’s TA Score shows that 4 TA indicator(s) are bullish while FHTX’s TA Score has 4 bullish TA indicator(s).

  • DMAC’s TA Score: 4 bullish, 4 bearish.
  • FHTX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, DMAC is a better buy in the short-term than FHTX.

Price Growth

DMAC (@Biotechnology) experienced а -5.98% price change this week, while FHTX (@Biotechnology) price change was +6.61% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.63%. For the same industry, the average monthly price growth was -7.17%, and the average quarterly price growth was -4.06%.

Reported Earning Dates

DMAC is expected to report earnings on Aug 12, 2026.

FHTX is expected to report earnings on Aug 11, 2026.

Industries' Descriptions

@Biotechnology (-3.63% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DMAC($292M) has a higher market cap than FHTX($227M). FHTX YTD gains are higher at: -28.333 vs. DMAC (-31.847). DMAC has higher annual earnings (EBITDA): -36.69M vs. FHTX (-78.02M). FHTX has more cash in the bank: 184M vs. DMAC (51.3M). DMAC has less debt than FHTX: DMAC (212K) vs FHTX (42M). FHTX has higher revenues than DMAC: FHTX (28.2M) vs DMAC (0).
DMACFHTXDMAC / FHTX
Capitalization292M227M129%
EBITDA-36.69M-78.02M47%
Gain YTD-31.847-28.333112%
P/E RatioN/AN/A-
Revenue028.2M-
Total Cash51.3M184M28%
Total Debt212K42M1%
FUNDAMENTALS RATINGS
DMAC: Fundamental Ratings
DMAC
OUTLOOK RATING
1..100
51
VALUATION
overvalued / fair valued / undervalued
1..100
53
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
90

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DMACFHTX
RSI
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
85%
Momentum
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
89%
MACD
ODDS (%)
Bearish Trend 1 day ago
80%
Bearish Trend 1 day ago
89%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
82%
Bullish Trend 1 day ago
88%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
87%
Advances
ODDS (%)
Bullish Trend 16 days ago
85%
Bullish Trend 7 days ago
86%
Declines
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 3 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
77%
Bearish Trend 1 day ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
DMAC
Daily Signal:
Gain/Loss:
FHTX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FSSKX101.21N/A
N/A
Fidelity Stock Selec-Class K
EQNTX24.64N/A
N/A
MFS Equity Income R3
MSQLX6.62N/A
N/A
Morgan Stanley Inst International Eq L
QNTAX40.51N/A
N/A
Meeder Sector Rotation Adviser
SPMWX10.51N/A
N/A
Invesco SteelPath MLP Select 40 R

FHTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, FHTX has been loosely correlated with XNCR. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if FHTX jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FHTX
1D Price
Change %
FHTX100%
+4.31%
XNCR - FHTX
43%
Loosely correlated
+4.03%
BEAM - FHTX
41%
Loosely correlated
+2.32%
ARVN - FHTX
40%
Loosely correlated
+0.77%
NKTX - FHTX
39%
Loosely correlated
+1.25%
EDIT - FHTX
39%
Loosely correlated
+0.38%
More